A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.

H Miyamoto; T Nakabayashi; H Isobe; H Akita; Y Kawakami; T Arimoto; M Asakawa; A Suzuki; T Fujikane; T Shimizu

doi:10.1159/000227087

A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.

Identifier:nobleid.org/w1/20260515/C1BA8F5F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C1BA8F5F.svg?ark=w1%2F20260515%2FC1BA8F5F)](https://nobleid.org/work/w1/20260515/C1BA8F5F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.

Identifier:nobleid.org/w1/20260515/C1BA8F5F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C1BA8F5F.svg?ark=w1%2F20260515%2FC1BA8F5F)](https://nobleid.org/work/w1/20260515/C1BA8F5F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work